Telomerase targeting drug demonstrates benefit in myelofibrosis treatment

2 septiembre 2015

Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a new study.
http://www.sciencedaily.com/releases/2015/09/150902191349.htm